VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Deshbandhu Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 33,429.05 Cr

Revenue (TTM): R 17,689.22 Cr

Earnings (TTM): R 318.63 Cr

Cash: R 3,097.06 Cr

Total Debt: R 8,496.15 Cr

Promoters' ownership: 46.93%

Liquidity: High

52 Week range: R 646.30 - 888.65

Face value: R2.00

Shares outstanding: 45,29,06,754

Stock Performance

Time Period Lupin S&P BSE Mid Cap S&P BSE Healthcare
YTD-3.504.905.04
1 month-3.855.935.36
3 months0.299.079.68
1 Year-14.605.500.28
3 Years-20.747.48-1.51
5 Years-13.097.98-1.88
10 Years9.948.7511.24
As on 23-Jan-2020
Year Lupin S&P BSE Mid Cap S&P BSE Healthcare
2019-9.27-3.05-3.55
2018-4.59-13.31-5.89
2017-40.4848.130.49
2016-19.427.97-12.88
201528.557.4315.06
201455.8054.6947.43
201347.74-5.7322.55

Review & Analysis